COPD virtual reality therapy market set for rapid growth
The market for virtual reality therapy in chronic obstructive pulmonary disease is projected to climb from $1.38 billion in 2025 to $3.33 billion by 2030, according to The Business Research Company. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.
Why it matters: - Virtual reality therapy is becoming a larger part of COPD care as providers look for non-drug tools that can support pulmonary rehabilitation, improve engagement and help patients manage symptoms. - The market’s growth signals rising demand for digital respiratory care, home-based treatment options and more personalized rehabilitation programs.
What happened: - The Business Research Company said the global COPD virtual reality therapy market rose from $1.38 billion in 2025 to an expected $1.65 billion in 2026. - The report projects the market will reach $3.33 billion by 2030. - The company released its chronic obstructive pulmonary disease Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.
The details: - COPD virtual reality therapy uses immersive virtual environments for respiratory rehabilitation. - The therapy combines interactive exercises, breathing techniques and real-time feedback. - The approach is designed to improve lung function, support symptom management and increase patient engagement. - VR therapy is being built into digital health platforms for both clinical and home-based pulmonary care. - The market report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report says the 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables. - The Business Research Company offers a free sample of the report. - The company also provides the full report.
Between the lines: - The growth drivers point to a wider shift toward non-pharmacological treatment options in chronic respiratory care. - The report links market expansion to pulmonary rehabilitation programs, rising COPD prevalence, broader acceptance of digital health tools, better access to VR hardware and stronger interest in remote respiratory care. - The U.S. Department of Veterans Affairs reported in July 2024 that it deployed about 3,500 VR headsets across more than 170 VA medical centers and clinics, showing how quickly clinical adoption can scale. - The report also connects market momentum to personalized medicine, where treatment plans are tailored to individual patient factors. - The U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, up from 12 in 2022, underscoring the broader shift toward customized care.
What's next: - The market is expected to keep expanding as providers adopt home-based VR pulmonary therapy, gamified rehabilitation modules, remote patient monitoring tools and immersive respiratory training systems. - The report forecasts stronger use of AI-driven personalized therapies and greater emphasis on patient adherence and engagement. - Wider adoption in homecare pulmonary management programs could broaden access beyond traditional clinical settings.
The bottom line: - COPD virtual reality therapy is moving from a niche digital health option toward a faster-growing rehabilitation market with room to scale across hospitals, clinics and home care.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
LATAM News Online
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.